| 大剂量天地欣治疗终末期肿瘤的疗效观察 |
| |
| 引用本文： | 姚春梅 张芬. 大剂量天地欣治疗终末期肿瘤的疗效观察[J]. 肿瘤防治研究, 1997, 24(5): 317-318 |
| |
| 作者姓名： | 姚春梅 张芬 |
| |
| 作者单位： | 安徽淮北矿工总医院 235000 |
| |
| 摘 要： | 1996年10～1997年3月间对39例终末期肿瘤病人行单纯支持对症加大剂量天地欣治疗。结果：综合组平均生存期15．4周和食欲改善率45％，显著优于单纯支持对症组7.79周和0％（P<0．01）。结论：大剂量天地欣结合支持对症治疗可延长终末期肿瘤病人生命且能提高生存质量。
|
| 关 键 词： | 大剂量 天地欣 终末期肿瘤 |
Treatment result for the terminal cancer with a Large dose of Tiandicin |
| |
| Yao Chunmei, et al. Treatment result for the terminal cancer with a Large dose of Tiandicin[J]. Cancer Research on Prevention and Treatment, 1997, 24(5): 317-318 |
| |
| Authors: | Yao Chunmei et al |
| |
| Affiliation: | Huaibei Miners General Hospital Huaibei 235000 |
| |
| Abstract: | 39 patients were treated by supporting theraphy alone and supporting theraphy plus high dose. Tiandicin from october, 1996 to March 1997. Results: The median survial period and the rate for impovement of appetite were 15. 4 weeks and 45% (9/20) in combination theraphy group and 7.79 weeks and 0% in supporting theraphyalone group (P<0.01). Conclusion: Using high dose Tiandicin and supporting theraphy will not only lengthen the lifetime of the terminal cancerous patients but also improve the quality of life. |
| |
| Keywords: | High dose Tiandicin The terminal cancer |
| 本文献已被 CNKI 维普 等数据库收录！ |
| 点击此处可从《肿瘤防治研究》浏览原始摘要信息 |
|
点击此处可从《肿瘤防治研究》下载免费的PDF全文 |
